Platelet indices in patients with pulmonary arterial hypertension

Clinical and Applied Thrombosis/Hemostasis

Volumn 17, Issue 6, 2011, Pages

  Varol, Ercan ^a   Uysal, Bayram Ali ^a   Ozaydin, Mehmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

mean platelet volume; platelet activation; platelet count; pulmonary arterial hypertension

Indexed keywords

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; RISK FACTORS;

EID: 84855864441     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029610394438     Document Type: Article

References (27)

1. Perros F, Dorfmüller P, Humbert M.. Current insights on the pathogenesis of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2005 ; 26 (4). 355-364 (Pubitemid 41266491)
2. Can MM, Tanboǧa IH, Demircan HC, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. Thromb Res. 2010 ; 126 (4). 280-282
3. Sakamaki F, Kyotani S, Nagaya N, et al. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Circulation. 2000 ; 102 (22). 2720-2725
4. Nakonechnicov S, Gabbasov Z, Chazova I, Popov E, Belenkov Y.. Platelet aggregation in patients with primary pulmonary hypertension. Blood Coagul Fibrinolysis. 1996 ; 7 (2). 225-227 (Pubitemid 26167950)
5. Lopes AA, Maeda NY, Almeida A, et al. Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology. 1993 ; 44 (9). 701-706 (Pubitemid 23263729)
6. Singer ST, Kuypers FA, Styles L, et al. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol. 2006 ; 81 (9). 670-675 (Pubitemid 44306825)
7. Park Y, Schoene N, Haris W.. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002 ; 13 (5-6). 301-306 (Pubitemid 34864514)
8. Boos CJ, Lip GY.. Assessment of mean platelet volume in coronary artery disease-what does it mean?. Thromb Res. 2007 ; 120 (1). 11-13 (Pubitemid 46601581)
9. Martin JF, Trowbridge EA, Salmon GL, Plumb J.. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res. 1983 ; 32 (5). 443-460 (Pubitemid 14243216)
10. Jakubowski JA, Thompson CB, Vaillancourt R, Valeri CR, Deykin D.. Arachidonic acid metabolism by platelets of differing size. Br J Haematol. 1983 ; 5 (3). 503-511 (Pubitemid 13153269)
11. Giles H, Smith REA, Martin JF.. Platelet glycoprotein IIb-IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994 ; 24 (1). 69-72 (Pubitemid 24204957)
12. Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S.. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007 ; 30 (1). 104-109 (Pubitemid 47074013)
13. Welsh CH, Hassell KL, Badesch DB, Kressin DC, Marlar RA.. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. Chest. 1996 ; 110 (3). 710-717 (Pubitemid 27009296)
14. Rubin LJ.. Primary pulmonary hypertension. N Engl J Med. 1997 ; 336 (2). 111-117 (Pubitemid 27020889)
15. Kamath S, Blann AD, Lip GY.. Platelet activation: assessment and quantification. Eur Heart J. 2001 ; 22 (17). 1561-1571 (Pubitemid 32801301)
16. Bath PM, Butterworth RJ.. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996 ; 7 (2). 157-161 (Pubitemid 26167943)
17. Kario K, Matsuo T, Nakao K.. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol. 1992 ; 14 (4). 281-287
18. Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004 ; 15 (8). 475-478 (Pubitemid 39656855)
19. Coban E, Ozdogan M, Yazicioglu G, Akcit F.. The mean platelet volume in patients with obesity. Int J Clin Pract. 2005 ; 59 (8). 981-982
20. Nadar S, Blann AD, Lip GY.. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med. 2004 ; 36 (7). 552-557 (Pubitemid 39490964)
21. Pathansali R, Smith N, Bath P.. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets. 2001 ; 12 (5). 292-297 (Pubitemid 32730516)
22. Berger G, Azzam ZS, Hoffman R, Yigla M.. Coagulation and anticoagulation in pulmonary arterial hypertension. Isr Med Assoc J. 2009 ; 11 (6). 376-379
23. Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010 ; 122 (9). 920-927
24. Debili N, Masse JM, Katz A, et al. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34Ş cells. Blood. 1993 ; 82 (1). 84-95 (Pubitemid 23188750)
25. Burstein SA, Downs T, Friese P, et al. Thrombocytopoiesis in normal and sublethally irradiated dogs: response to human interleukin-6. Blood. 1992 ; 80 (2). 420-428
26. Muscari A, De Pascalis S, Cenni A, et al. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost. 2008 ; 99 (6). 1079-1084 (Pubitemid 351810490)
27. Vizioli L, Muscari S, Muscari A.. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract. 2009 ; 63 (10). 1509-1515